EUCTR2013-004189-33-NO进行中（未招募）不适用
TRADIAN SUBCUTANEOUS HYDROCORTISONE (USHI) INFUSION IN ADDISON’S DISEASE
Haukeland University Hospital0 个研究点目标入组 10 人开始时间: 2013年10月30日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with verified Addison`s disease , age 18-65, will be included. In case of other concomitant endocrine/autoimmune diseases these should be on stable treatment during the study period. The patient will have to give written informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Exclusion criteria are cardiovascular disease, active malignant disease and pregnancy, and pharmacological treatment with glucocorticoids or drugs that interfere with cortisol metabolism (antiepileptics, rifampicin, St. Johns war, estrogens).The patients should not take grapefruit juice the last two weeks before or during the study period.
研究者
相似试验
进行中（未招募）
1 期
A trial comparing continuous subcutaneous hydrocortisone infusion (CSHI) therapy with conventional oral glucocorticoid therapy in patients with Congenital Andrenal Hyperplasia (CAH)Congenital Adrenal HyperplasiaMedDRA version: 14.1Level: LLTClassification code 10010323Term: Congenital adrenal hyperplasiaSystem Organ Class: 100000004850EUCTR2011-005822-23-SEHaukeland University Hospital20
进行中（未招募）
不适用
A trial comparing continuous subcutaneous hydrocortisone therapy with conventional oral glucocorticoid therapy in congenital adrenal hyperplasiaCongenital adrenal hyperplasia (CAH)MedDRA version: 14.1Level: LLTClassification code 10010323Term: Congenital adrenal hyperplasiaSystem Organ Class: 100000004850EUCTR2011-005822-23-NOHaukeland University Hospital
尚未招募
Unknown
Pharmacist Driven Effective Use of Topical CorticosteroidsCTRI/2023/05/053287Sreeraj K
招募中
不适用
Prevention of antivenom reactions by administering intravenous hydrocortosne 2 hours before antivenom treatmentSnake bite,antivenom reactionsSLCTR/2010/005Prof SAM Kularatne
已完成
Unknown
Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) Prevention of Relapse of Multiple SclerosisMultiple sclerosisJPRN-jRCT1080223004TAKEDA PHARMACEUTICAL COMPANY LTD.1,332